Skip to main content

Results of the Adaptive Servo Ventilation (ASV) product correction notice

In May 2015, the manufacturers of Adaptive Servo Ventilators (ASV) announced a product correction notice. Within less than 3 weeks of the issue of the initial product correction notice, Air Liquide Healthcare was 100% successful in contacting all prescribers.

This outstanding accomplishment demonstrates Air Liquide Healthcare’s capacity to respond quickly.

Typically with a product correction notice patients are not contacted directly. Instead the patient’s physician is alerted to ensure that they review the appropriateness of the device with each of their patients.

Air Liquide Healthcare anticipated that the product correction notice would affect these devices from all manufacturers. We compiled data for all ASV models and proactively contacted each physician in writing and by phone with a list of all of their patients that had fulfilled their prescription for ASV therapy through one of our many clinics.